Fakeeh Hospital Company and its subsidiaries (“Fakeeh Care Group”, “FCG”, “Fakeeh Care”, the “Company” or “Group”), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), will announce on Wednesday its financial results for the third quarter ended December 31st. 2025.
Fakeeh Care Group recorded revenue of SR3.1 billion in FY25, an increase of 11% year-on-year. Growth was driven by patient volume expansion across the group and continued evolution of case mix towards higher value and complex care. The group served 1.9 million patients annually, with outpatients increasing 8%, inpatients increasing 9% and surgeries increasing 9%, representing an 8% increase over the previous year. The Group’s mature businesses, including the Jeddah-based facility and home care, continued to support the performance, while the Group’s new hospitals in Riyadh and Madinah, which constitute new business, increased their contribution as they expanded their capacity and deepened their service lines. With the continued expansion at DSFH Riyadh and the phased opening of DSFH Madina, the number of active beds reached 544 beds in Q4 2025 and 457 beds in Q4 2024.
Across the group’s facilities, inpatient occupancy averaged 81% in FY25 despite an expanded bed base. DSFH Jeddah maintained an occupancy rate of over 80% throughout the year, and DSFH Riyadh continued to have an occupancy rate of over 80% in Q4 2025, with the development of more advanced specializations. DSFH Medina reported a sharp increase early on, providing patients with strong demand for quality care in Medina.
Group performance comments from FCG president
Dr. Mazen Soliman Fakih said:
“In 2025, Fakeeh Care It was a year of disciplined delivery for the Group. The company ended the year with revenues of SAR 3.1 billion, an increase of 11% year-on-year, and served 1.89 million patients, an increase of 8% year-on-year, but growth is only valuable when delivered under operational management. Throughout the year, we maintained broad throughput growth and continued to hone our clinical mix toward higher value and complex care. We also expanded our operations, increasing capacity across our network and increasing geographic diversification, while maintaining high utilization and patient flow discipline across our ecosystem.
Our mature platform in Jeddah continues to maintain standards, clinical depth and operational rhythm. New hospitals in Riyadh and Madinah are expanding access to catchments that are in high demand but are underserved by complex services. We continue to treat expansion and growth as capacity building. This means embedding clinical governance, pathways and service line sequencing from day one to strengthen the group’s platform through growth. This is how you build a national network that delivers consistent results. ”
Quality and external validation remained key themes throughout the year. DSFH Jeddah continued to strengthen third-party evaluation of its clinical governance and complex care capabilities. The hospital was designated as a Pioneer Hospital under the Health Insurance Council’s Daman Classification Program after achieving a score of 110% on mandatory and voluntary criteria, setting new national standards, and strengthening its alignment with values-based care. The facility also received the SRC Institutional Commitment to Excellence Award, making it the first hospital in the world to receive this award and continuing its track record of internal reaccreditation by the Saudi Specialty Medical Council. Also during the year, DSFH Jeddah became the first private hospital in Saudi Arabia to receive CBAHI accreditation for acute coronary syndrome services, and its outpatient and specialty hospital performance was recognized in regional and international rankings by Newsweek and Statista.
Dr. Marzen said:
“Throughout the year, our platform continued to undergo external validation of clinical governance and operational standards. DSFH Jeddah was designated a Pioneer Hospital under the Health Insurance Council’s Daman Classification Program after achieving a score of 110% against mandatory and voluntary criteria. This designation strengthens payer confidence and supports the emerging nation of value-based care. Home benchmarks were set. We also built a systems-level approach to quality and continually advanced assessments that strengthened our complex care capabilities and patient safety standards. These milestones are proof that our operating model is measurable, repeatable, and resilient to scale. ”
Education continued to support the group’s long-term competency base. Through the Fakeeh College for Medical Sciences (FCMS), the Group expanded its training capacity and strengthened clinical preparation, in line with the Kingdom’s localization challenges and long-term sustainability goals. The 6,500 square meter Simulation & Clinical Skills Center is now complete and operational. It has 15 classrooms, 12 laboratories and 18 OSCE rooms and can train up to 500 students per day. The average number of students increased by 9% in FY25 compared to FY24, reinforcing FCMS’ role in training Fakeeh Care Group and ready-to-work Saudi clinicians across the Kingdom.
Dr. Mazen added:
“Capacity development in Saudi remains one of the sector’s clear priorities.Through the Faqih University of Medical Sciences, we continued to expand our training capacity and enhance clinical readiness, in line with Saudi localization challenges and long-term sustainability goals. We view education and clinical development as our core infrastructure, which will uphold our standards as we scale, support our multidisciplinary delivery, and build the pipeline we need to meet increased demand without compromising quality.”
As part of the group’s Riyadh expansion strategy, Fakeeh Care Group is in advanced discussions to acquire a majority stake in Dr Mohammad Al Faghi Hospital (Riyadh). The transaction is expected to strengthen the group’s footprint by adding immediate production capacity in a market with growing demand. Discussions are ongoing and are subject to completion of due diligence, final documentation and customary regulatory approvals. In parallel, the Group plans to introduce three new clinics to its network, starting with the strategically located DSFMC Alawali in Mecca, followed by DSFMC North Obhur and DSFMC Al-Zahra’a in Jeddah, on track to have more than 100 clinics by 2026, in response to the growing demand for quality community healthcare in these catchment areas.
Dr. Mazen concluded:
Related articles
Saudi Awal Bank becomes first bank in the Middle East to achieve 7-star CinOrg®️ Innovation Certification
“Looking to the future, we will continue to build capabilities and leverage while safeguarding the stable performance of the group’s mature businesses. We will continue to deepen the tertiary capabilities that demand requires. We will remain disciplined in our operational rhythm, governance and capital allocation. Above all, we continue to scale in a way that strengthens trust – the trust of patients, payers, regulators and shareholders who expect disciplined execution and clear accountability – a resilient core, an expanding footprint, and an increasingly validated model.” With a presence in multiple regions, Fakeeh Care Group is well-positioned to create lasting value for our patients, staff, students, shareholders and the broader community. ”
Fakeeh Care Group’s complete 2025 financial results release can be downloaded from en.fakeeh.care.
About Fakeeh Care Group
Founded in 1978 by the late Dr. Soliman Fakeeh, Fakeeh Care Group has established itself as a pioneer in integrated healthcare services in Saudi Arabia. Our comprehensive medical services include core medical services ranging from outpatient care to secondary and tertiary care, supported by emergency medical services and Fakeeh Home Healthcare. Additionally, our services are enhanced by industry-leading academic healthcare programs. Building on its strong growth record in its home base of Jeddah, the Group has embarked on a Kingdom-wide expansion strategy to bring its proven hub-and-spoke model and medical support services to major cities across Saudi Arabia.
In June 2024, Fakeeh Care Group successfully completed the initial public offering (IPO) of Tadawul. The IPO will raise gross proceeds of SR2.9 billion (US$764 million) for the Company and the selling shareholders, of which SR1.7 billion will be used to support and accelerate the Group’s growth strategy.
For more information, please contact us below.
Faki Care Group
Email: (email protected)
Forward-looking statements
This communication contains certain forward-looking statements. Forward-looking statements are any statements that do not relate to historical facts or events and can be identified by the use of words or phrases such as “estimated,” “expect,” “assume,” “believe,” “could,” “estimate,” “expect,” “intend,” “opinion,” “may,” “plan,” “could,” “predict,” “predict,” or similar words or phrases. “should”, “to the best of our knowledge”, “will”, “will” or, in each case, the negative thereof or other similar expressions intended to identify forward-looking statements. This applies in particular to statements containing information regarding future financial results, plans or expectations regarding our business and operations, future growth or profitability, general economic and regulatory conditions, and other matters affecting us.
These forward-looking statements are subject to risks, uncertainties and assumptions regarding the Company and its subsidiaries and their investments. This includes, among other things, the business development, financial situation, outlook, growth, strategy, industry trends and macroeconomic developments in the Kingdom of Saudi Arabia. Many of these risks and uncertainties relate to factors beyond our control or accurate estimation, such as future market conditions, currency fluctuations, the actions of other market participants, the actions of regulatory authorities, applicable laws and regulations, and changes in government policy. Given these risks, uncertainties and assumptions, the events described in the forward-looking statements may not otherwise occur, and past performance is no guarantee of future results. No representation or warranty is made with respect to forward-looking statements made by the Company. We do not intend to update, supplement, amend or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. Nothing in the information should be construed as a prediction of profit.
The information may include financial information that is not defined or recognized under International Financial Reporting Standards (IFRS). These measures are derived from our consolidated financial statements and are provided as additional information to supplement the IFRS measures. The financial information we provide should not be considered in isolation or as a substitute for analysis of our financial information reported under IFRS.
